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Human stratum corneum chymotryptic enzyme
(SCCE) may play a central part in epidermal homeost-
asis. Its proposed function is to catalyze the degrada-
tion of intercellular structures, including desmosomes,
in the stratum corneum as part of the desquamation
process. In order to facilitate physiologic and patho-
physiologic studies on SCCE we have looked for the
corresponding murine enzyme. A cDNA obtained by
reverse transcription-polymerase chain reaction with
total RNA prepared from mouse tails as starting mat-
erial was cloned, and the expression of the correspond-
ing mRNA studied. The murine cDNA showed 77%
homology to human SCCE cDNA. It had an open-
reading frame encoding a protein comprising 249
amino acids with 82% amino acid sequence homology
to human SCCE including the conserved sequences of
the catalytic triad of mammalian serine proteases. The
murine protein was deduced to have a 21 amino acid
Stratum corneum chymotryptic enzyme (SCCE; EC3.4.21; Swiss Prot P49862) is a chymotrypsin-like serineprotease which was originally purified from the outermostlayer, the stratum corneum, of human plantar skin(Egelrud, 1993). It has been suggested that the function of
SCCE is to catalyze the degradation of intercellular structures
(Lundstro¨m and Egelrud, 1990a), including desmosomes
(Lundstro¨m and Egelrud, 1990b; Sondell et al, 1995), in the stratum
corneum as part of a well regulated process leading to decreased
cellular cohesion and eventually desquamation. SCCE may thus
play a central part in epidermal homeostasis (Egelrud et al, 1996).
On the basis of biochemical analyses and in vitro experiments it has
also been suggested that SCCE can act as an activating protease for
precursors of pro-inflammatory cytokines, especially interleukin-
1β, in the skin (Nylander-Lundqvist et al, 1996; Nylander-Lundqvist
and Egelrud, 1997a, b; Brattsand and Egelrud, 1998).
On the protein level expression of human SCCE has so far been
detected only in squamous epithelia undergoing cornification
(Sondell et al, 1994, 1996; Ekholm et al, 1998). Northern blot
analyses have shown high SCCE expression in the skin, and a low
but still detectable expression in the kidney and brain (Hansson
et al, 1994).
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signal peptide and a four amino acid propeptide ending
with a tryptic cleavage site, followed by a sequence
motif identical to the N-terminal amino acid sequence
of native active human SCCE. As in human SCCE the
P2 position of the propeptide was occupied by an acidic
amino acid residue, and the position corresponding
to the suggested bottom of the primary substrate
specificity pouch occupied by an asparagine residue.
Analyses of mouse tissues by reverse transcriptase–
polymerase chain reaction showed high expression in
the skin, low expression in lung, kidney, brain, heart,
and spleen, and no expression in liver or skeletal
muscle. In situ hybridization of mouse skin showed
expression in high suprabasal keratinocytes and in the
luminal parts of hair follicles. Our results strongly
suggest that we have cloned the murine analog of
human SCCE cDNA. Key words: desquamation/serine
protease. J Invest Dermatol 113:152–155, 1999
The proposed function of SCCE in normal skin physiology,
although supported by some indirect evidence (Egelrud et al, 1996),
has still to be proven. The same holds true for the possible
involvement of SCCE in skin pathophysiology, including inflam-
matory reactions (Nylander-Lundqvist et al, 1996; Nylander-
Lundqvist and Egelrud, 1997a, b; Brattsand and Egelrud, 1998).
In order to facilitate further studies on SCCE we have looked
for analogous enzymes in experimental animals. In this work we
report on the molecular cloning and tissue expression of a protease
which may be the murine analog of human SCCE.
MATERIALS AND METHODS
Cloning of murine scce cDNA Tail biopsies from C57/B1 mice were
utilized for the preparation of total RNA as described (Chomczynski and
Sacchi, 1987) followed by isolation of mRNA using the PolyATract
mRNA Isolation System (Promega, Madison, WI). The prepared mRNA
was then subjected to reverse transcription primed by pd(N)6 random
hexamers. In order to amplify SCCE sequences specifically, degenerate
primers were designed corresponding to the conserved amino acid sequence
motifs found in serine proteases; TAAHC and GDSGGP, resulting in SYM
3971 (59-GCCGGTCGACNGGCNGCNCAYTGY-39), SYM 3974 (59-
CCGGCAAGCTTNGGNCCNCCNGARTCNCC-39), and SYM 3975
(59-CCGGCAAGCTTNGGNCCNCCRCTRTCNCC-39), respectively.
The polymerase chain reaction (PCR) amplified fragments were then
cloned into SalI/HindIII digested pUC19. By colony hybridization utilizing
a 900 bp EcoRI/DraI fragment isolated from human scce cDNA as a probe
(Hansson et al, 1994) hybridizing colonies were isolated and sequenced.
Two of these plasmids were found to harbor fragments of 430 bp which
showed high homology to human scce. One of these plasmids was designated
pS506. By using this 430 bp fragment as a probe, a genomic sequence
from a murine genomic library of SVJ129 origin (Stratagen, La Jolla, Ca)
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Figure 1. Translated nucleotide sequence of murine scce. GenBank accession number: AF124299.
was isolated. The exon/intron borders and exon sequences were determined
and compared with the human cDNA sequence (Hansson et al, 1994). To
clone the 59 flanking sequence, translation initiation, and sequences
overlapping the fragment cloned into pS506, mRNA was prepared from
tail biopsies with Dynabeads (Dynal, Oslo, Norway) according to instruc-
tions from the manufacturer and subjected to reverse transcription using
the Amplifinder RACE kit (Clontech Laboratories, Palo Alto, CA). A
fragment was PCR amplified by using primers: anchor primer AP1
(59-CCATCCTAATACGACTCACTATAGGGC-39) and SYM 4302 (59-
TCTGGGCTGGTTGTGGTGCC-39) followed by a nested PCR using
anchor primer AP2 (59-ACTCACTATAGGGCTCGAGCGGC-39) and
SYM 4289 (59-CGCGAAGCTTGTTCAGGAAGCTGGACTGC-39).
The two primers, SYM 4289 and SYM 4302, were complementary to
sequences specific for the fragment harbored by the plasmid pS506. The
resulting fragment was isolated by EcoRI and HindIII, cloned into pUC19,
and designated pS784.
To construct a full-length cDNA, a EcoRI/PvuII fragment of 311 bp
from pS784 containing sequence encoding for amino acid residues 1–50
and 59 untranslated sequence, and a 388 bp PvuII/HindIII fragment isolated
from pS506 containing sequence encoding for amino acid residues 51–179
were isolated. These two fragments were ligated into EcoRI/HindIII
digested pUC19 resulting in pS785. To include the sequence encoding
the last 45 amino acid residues the method for construction of chimeric
molecules by a two-step recombinant PCR method (Pont-Kingdon, 1994)
was utilized. The plasmids pS732 and pS785 were utilized as templates and
SYM 4633 (59-CTAAGACCAACACGTGCAATGGTGACTCAGGGG-
GGCCCTTG-39), SYM 4634 (59-CCAGGGACGTCATGTACCGTC-
39), and SYM 4632 (59-CGGCGTCGACGCTCACAGCTCGGCT-
CCTGCCATGTTAGCGAT-39) were utilized as PCR primers, generating
a 363 bp fragment after digestion with AatII and SalI. This 363 bp fragment
was ligated with the 511 bp EcoRI/AatII fragment derived from pS785.
These two fragments covering the murine SCCE encoding sequence
resulted in pS786 after ligation into EcoRI/SalI digested pUC19. The
nucleotide sequence was determined using a T7 sequencing kit (Pharmacia
Biotech, Uppsala, Sweden).
Reverse transcriptase–PCR For reverse transcriptase–PCR furred
C57BL/6 mice were killed through cervical dislocation. Organs were
immediately dissected, frozen in liquid nitrogen, and stored at –80°C until
further processed. Approximately 100 mg of frozen tissue was homogenized
using a Mikro-Dismembranator U (B. Braun Biotech International GmbH,
Melsungen, Germany) at 2000 r.p.m. for 45 s. The homogenate was
transferred to 1 ml of Trizol Reagent (Life Technologies AB, Ta¨by, Sweden)
and RNA was isolated according to the manufacturer’s instructions. The
quality of the isolated RNA was assessed by agarose gel electrophoresis.
The preparations were subjected to DNase treatment; extracted with
phenol/CHCl3, and precipitated with LiCl according to the Boehringer
Mannheim protocol (Nonradioactive In Situ Hybridization Application
Manual, Boehringer Mannheim, Mannheim, Germany). The RNA was
redissolved in RNase-free water and stored at –80°C until used.
Reverse transcriptase–PCR was performed as described (Lindstro¨m et al,
1996) with oligo d(T)16 primers (Perkin Elmer, Foster City, CA) in the
reverse transcriptase reaction. In each reverse transcriptase reaction 100 ng
of total RNA was used. For PCR each incubation mixture was split into
three and transferred to new reaction tubes in order to amplify murine scce
and β-actin separately. A negative control with the reverse transcriptase
omitted was always run for each sample of RNA. In addition a negative
control without any added RNA was always run in parallel with the test
samples. Three murine scce primers were synthesized, mS1, corresponding
to bp 582–603 in the mouse cDNA (59-GAAGCTCATCTCCTCCAGG-
GAG-39); mS3, corresponding to bp 154–178 in the mouse cDNA (59-
CAAGGAGAAAGGATTATAGATGGCT-39); and mS4, corresponding to
bp 817–840 in the mouse cDNA (59-TTAGCGATGGGTTTTCATGGT-
CTC-39). The expected amplified PCR products are 687 bp (mS3–mS4)
and 259 bp (mS1–mS4). Primers for mouse β-actin, expected PCR
fragment 162 bp, were a generous gift from Dr Pernilla Wikstro¨m,
Department of Urology, Umeå University. PCR was performed according
to standard protocols using Taq DNA polymerase (Boehringer Mannheim)
with 40 cycles. The authenticity of the murine scce PCR products from
skin, heart, and lung was verified by means of nucleotide sequencing.
In situ hybridization Pieces of tails from C57BL/6 mice were cut,
immediately embedded in Tissue-Tek OCT Compound (Miles, Elkhart,
IN) and snap frozen in liquid propane chilled with liquid nitrogen. In situ
hybridization was carried out with digoxygenin labeled sense and anti-
sense RNA probes corresponding to a segment spanning bp 292–686 of
the murine scce cDNA. The protocol by Panoskaltsis-Mortari and Bucy
(1995) was used except for the blocking step, where goat serum was used.
Bound probes were detected with alkaline phosphatase conjugated anti-
digoxygenin Fab fragments and 4-nitroblue tetrazolium chloride/5-bromo-
4-chloro-3-indolyl-phosphate (Boehringer Mannheim) as chromogenic
substrate.
RESULTS
Identification and isolation of murine SCCE cDNA Total
RNA was prepared from mouse tail biopsies, C57/Bl, and subjected
to reverse transcriptase–PCR amplification. To obtain a mouse-
specific sequence, degenerate PCR primers complementary to the
two regions encoding the conserved motifs, TAAHC and GDSGGP,
were designed (see Materials and Methods) The amplified DNA was
analyzed by southern hybridization utilizing a 900 bp EcoRI/DraI
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Figure 2. Comparison between the deduced amino acid sequences of human and murine SCCE. The numbering refers to the human protein.
Underlined italics, propeptide; underlined capitals, conserved amino acid sequences of the catalytic triad; |, full homology; 1, homology as regards functional
group of amino acid side chain; –, no homology.
fragment isolated from the human cDNA as a probe (Hansson et al,
1994). A distinct hybridizing band appeared indicating the presence
of a transcript homologous to SCCE in the preparation. The PCR
results in a 430 bp fragment that shows about 77% identity to the
corresponding region in the human cDNA sequence. To obtain a
full-length murine cDNA sequence, the 59 fragment was isolated
by PCR and the 39 part was isolated from a genomic clone, detailed
in the Materials and Methods section. These fragments were then
combined resulting in a 874 bp murine SCCE cDNA fragment
and cloned into EcoRI/SalI digested pUC19, resulting in pS786.
The nucleotide sequence of the murine cDNA is shown in Fig 1.
The obtained sequence contains an open-reading frame of 747 nt
preceded by an untranslated leader sequence of 90 nt and a
31 nt 39-untranslated sequence. The open-reading frame encodes
a deduced precursor protein sequence that comprises 249 amino
acid residues, compared with 253 for the human precursor protein
(Hansson et al, 1994), with an IIDG motif. This sequence motif
has been shown to be the amino terminus of catalytically active
human SCCE (Hansson et al, 1994). Assuming that this terminus
is conserved between mouse and humans, the tentative signal
peptide of mouse SCCE comprises 21 amino acid residues and the
propeptide 4 amino acid residues (Fig 2). The human SCCE
preproprotein contains 22 and seven amino acid residues in the
signal peptide and propeptide, respectively. After alignment and
comparison the overall homology for the deduced active murine
and human enzymes, 223 amino acid residues in both species, was
found to be 79% (83% if residues with similar functional groups
were included; Fig 2). The deduced amino acid sequence contains
the conserved amino acids comprising the catalytic triad of mamma-
lian serine proteases. The homology between human and mouse
SCCE includes the asparagine at position 170 (Hansson et al, 1994).
Tissue expression of murine SCCE Total RNA was prepared
from murine tissues and analyzed by means of reverse transcriptase–
PCR with PCR primers based on the nucleotide sequence of
murine SCCE cDNA. The results are shown in Fig 3. With PCR
primers mS3–mS4 products with the expected size (687 bp) could
be detected for brain, kidney, heart, and skin. With primers mS1–
mS4 products with the expected (259 bp) size could be detected
Figure 3. Detection of mRNA for murine SCCE in mouse tissues
by means of reverse transcriptase–PCR. I and IV, PCR primers mS3–
mS4 (expected product 687 bp); II and V, PCR primers mS1–mS4
(expected product, 259 bp); III, PCR primers for actin (expected
product, 162 bp); VI, PCR primers mS1–mS4; no reverse transcriptase.
Volume of PCR mixtures applied, 2 µl in (A), 10 µl in (B). Lane 1,
1 kb DNA Ladder standard (Life Technologies AB, Ta¨by, Sweden);
arrows, markers: from top 1018 bp, 514/506 bp, and 220 bp. Lanes 2–
10, brain, liver, kidney, spleen, lung, heart, skeletal muscle, skin, and
negative control, respectively. In the negative control water instead of
RNA was added to the reverse transcriptase mixture, and PCR performed
with the mS1–mS4 primer pair.
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Figure 4. Murine SCCE is expressed by high suprabasal
keratinocytes and keratinocytes in the luminal parts of hair follicles
in normal mouse tail. In situ hybridization with murine scce-specific
RNA probes. (A) Anti-sense probe; (B) sense probe (negative control).
hf, hair follicle; sc, stratum corneum. Scale bar: 50 µm.
for the same organs, but also for spleen and lung. Similar results
were obtained in analyses of tissues from three different animals.
The products from skin, heart, and lung were cloned, and their
nucleotide sequences verified as being identical to appropriate parts
of murine SCCE cDNA (results not shown). Semiquantitative
analyses (see Fig 3 and legend) showed a much higher expression
of murine SCCE in skin than in any of the other tissues in which
expression could be detected. No expression was found in liver or
skeletal muscle.
In situ hybridization with an anti-sense probe based on the
murine SCCE cDNA showed expression in the uppermost viable
cell layers of the epidermis, as well as in the luminal part of the
hair follicle (Fig 4A). Control experiments using the corresponding
sense probe were negative (Fig 4B).
DISCUSSION
In this work we present the nucleotide sequence of a murine
cDNA which shows 77% homology to the human SCCE cDNA.
The mouse cDNA has an open-reading frame encoding a protein
with a deduced amino acid sequence, which is homologous to the
deduced amino acid sequence of human SCCE to approximately
80%. The deduced murine protein shares a number of unique
features with human SCCE. This holds true for the nature of the
propeptide, with an acidic amino acid residue at the P2 residue of
the suggested tryptic activation site, and the amino acid residue
(Asn) at the suggested bottom of the primary substrate specificity
pouch (position 170) (Polga´r, 1987).
High tissue expression at the mRNA level was found with
reverse transcriptase–PCR in skin, whereas a lower but detectable
expression was seen in heart, lung, kidney, spleen, and brain. This
should be compared with human SCCE, for which high expression
was found in skin and low levels in kidney and brain by means of
northern blotting (Hansson et al, 1994). In analyses by means of
in situ hybridization of mouse tails with an RNA probe specific
for murine SCCE, expression was seen in high epidermal cells and
in luminal parts of the hair follicle, i.e., a pattern which is similar
to what has been found for human SCCE (Sondell et al, 1997) On
the protein level expression of the human enzyme has been detected
so far only in high suprabasal cells of cornifying squamous epithelia
(Sondell et al, 1994, 1996; Ekholm et al, 1998). It remains to be
elucidated if this will hold true also for murine SCCE.
Taken together these findings strongly suggest that the cDNA
presented herein encodes a protein which is the mouse analog of
human SCCE. The availability of this information will hopefully
facilitate further studies on the function of SCCE in normal and
pathologic skin physiology.
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